Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...

Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

Partnered Assets: SIRPa antagonists BI 765063 and BI 770371, an improved next generation SIRPa inhibitor, developed in partnership with Boehringer Ingelheim: Rapid Oral Abstracts of the Phase 1 ...

Gender inclusivity and bias mitigation in MT is another key theme. The 3rd International Workshop on Gender-Inclusive ...